Experimental Parasitology 2010-09-01

Acanthamoeba castellanii Neff: In vitro activity against the trophozoite stage of a natural sesquiterpene and a synthetic cobalt(II)-lapachol complex.

Carmen M Martín-Navarro, Atteneri López-Arencibia, Jacob Lorenzo-Morales, Sandra Oramas-Royo, Rita Hernández-Molina, Ana Estévez-Braun, Angel G Ravelo, Basilio Valladares, José E Piñero

Index: Exp. Parasitol. 126(1) , 106-8, (2010)

Full Text: HTML

Abstract

In this study, the in vitro activities of a natural sesquiterpene, alpha-cyperotundone, isolated from the root bark of Maytenus retusa and a cobalt(II)-complex of a natural occurring prenyl hydroxynaphthoquinone (lapachol) were evaluated against the trophozoite stage of Acanthamoeba castellanii Neff using a previously developed colorimetric 96-well microtiter plate assay, based on the oxido-reduction of Alamar Blue(R). The obtained activities showed that these two compounds were able to inhibit the in vitro growth of the amoebae at relatively low concentrations. Further identification of the molecular targets of these products and their effects on acanthamoebae should be determined to evaluate their possible therapeutic use.Copyright 2010. Published by Elsevier Inc.

Related Compounds

  • Lapachol

Related Articles:

Quinones derived from plant secondary metabolites as anti-cancer agents.

2013-03-01

[Anticancer Agents Med. Chem. 13(3) , 456-63, (2013)]

Organometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicity.

2013-04-25

[Chem. Commun. (Camb.) 49(32) , 3348-50, (2013)]

Antiproliferative activity of synthetic naphthoquinones related to lapachol. First synthesis of 5-hydroxylapachol

2010-04-01

[Bioorg. Med. Chem. 18 , 2621-30, (2010)]

Determination of lapachol in the presence of other naphthoquinones using 3MPA-CdTe quantum dots fluorescent probe.

2013-01-01

[Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 100 , 155-60, (2013)]

Biomimetic in vitro oxidation of lapachol: a model to predict and analyse the in vivo phase I metabolism of bioactive compounds.

2012-08-01

[Eur. J. Med. Chem. 54 , 804-12, (2012)]

More Articles...